Literature DB >> 25352076

Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.

Michael Bergman1, Angela Chetrit, Jesse Roth, Rachel Dankner.   

Abstract

BACKGROUND: We describe the relationship between dysglycemia and long-term mortality and elucidate the relationship between blood glucose levels during an oral glucose tolerance test (OGTT) and haemoglobin A1 (HbA1) and mortality.
METHODS: A cohort of 1410 individuals was followed for 33 years since 1980. Fasting and post-OGTT glucose parameters were used to categorize the cohort according to baseline glycemic status.
RESULTS: The mortality rate increased from 43% in normoglycemic individuals to 53.3, 61.7, 72.9 and 88.0% in those with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), IFG/IGT and diabetes, respectively. The highest mortality rate, compared with the normoglycemic category, was observed in individuals with IFG/IGT and diabetes according to a Cox proportional hazard model (HR = 1.38, 95%CI 1.10-1.74 and HR = 2.14, 95%CI 1.70-2.70, respectively), followed by individuals with IGT and IFG, but this did not reach statistical significance. We speculate that the IFG group may represent a mixture of individuals en route from normal to the next two categories as well as another cohort whose glucose levels are stably set at the upper reaches of the normal distribution. Significant differences were found between 1 and 2 h glucose values (p < 0.001). Fasting, 60 and 120 min glucose values were positively associated with increasing HbA1 quintiles (p < 0.05). The mean HbA1 was significantly higher in those who died (p = 0.01). The highest mortality (58.8%) was observed in the upper HbA1 quintile that was also associated with the highest prevalence of the metabolic syndrome (17.2%).
CONCLUSIONS: This study shows a continuous relationship between the severity of dysglycemia and long-term mortality and should promote the early recognition of prediabetes. The 1 h post-load glucose level was continuously associated with increasing HbA1 concentrations and may therefore serve as an early marker for abnormalities in glucose tolerance. An elevated 1 h post-load glucose level may potentially identify at-risk individuals well before the traditional 2 h glucose value.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HbA1c; OGTT; dysglycemia; metabolic syndrome; mortality; prediabetes; prevention

Mesh:

Substances:

Year:  2014        PMID: 25352076     DOI: 10.1002/dmrr.2618

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  8 in total

1.  Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Authors:  Michael Bergman; Ram Jagannathan; Martin Buysschaert; Jose Luis Medina; Mary Ann Sevick; Karin Katz; Brenda Dorcely; Jesse Roth; Angela Chetrit; Rachel Dankner
Journal:  Endocrine       Date:  2017-01-25       Impact factor: 3.633

2.  Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk.

Authors:  Adam Hulman; Rebecca K Simmons; Dorte Vistisen; Adam G Tabák; Jacqueline M Dekker; Marjan Alssema; Femke Rutters; Anitra D M Koopman; Thomas P J Solomon; John P Kirwan; Torben Hansen; Anna Jonsson; Anette Prior Gjesing; Hans Eiberg; Arne Astrup; Oluf Pedersen; Thorkild I A Sørensen; Daniel R Witte; Kristine Færch
Journal:  Endocrine       Date:  2016-10-03       Impact factor: 3.633

3.  Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting.

Authors:  Ram Jagannathan; Mary Ann Sevick; Huilin Li; Dorothy Fink; Rachel Dankner; Angela Chetrit; Jesse Roth; Michael Bergman
Journal:  Endocrine       Date:  2015-09-29       Impact factor: 3.633

4.  Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.

Authors:  Adam Hulman; Dorte Vistisen; Charlotte Glümer; Michael Bergman; Daniel R Witte; Kristine Færch
Journal:  Diabetologia       Date:  2017-10-06       Impact factor: 10.122

5.  Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: The CRONICAS Cohort Study.

Authors:  Maria Lazo-Porras; Antonio Bernabe-Ortiz; Andrea Ruiz-Alejos; Liam Smeeth; Robert H Gilman; William Checkley; German Málaga; J Jaime Miranda
Journal:  Diabetes Res Clin Pract       Date:  2019-08-26       Impact factor: 5.602

6.  Post-load glucose subgroups and associated metabolic traits in individuals with type 2 diabetes: An IMI-DIRECT study.

Authors:  Morgan Obura; Joline W J Beulens; Roderick Slieker; Anitra D M Koopman; Trynke Hoekstra; Giel Nijpels; Petra Elders; Robert W Koivula; Azra Kurbasic; Markku Laakso; Tue H Hansen; Martin Ridderstråle; Torben Hansen; Imre Pavo; Ian Forgie; Bernd Jablonka; Hartmut Ruetten; Andrea Mari; Mark I McCarthy; Mark Walker; Alison Heggie; Timothy J McDonald; Mandy H Perry; Federico De Masi; Søren Brunak; Anubha Mahajan; Giuseppe N Giordano; Tarja Kokkola; Emmanouil Dermitzakis; Ana Viñuela; Oluf Pedersen; Jochen M Schwenk; Jurek Adamski; Harriet J A Teare; Ewan R Pearson; Paul W Franks; Leen M 't Hart; Femke Rutters
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

7.  Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.

Authors:  Halla Kaminska; Lukasz Szarpak; Dariusz Kosior; Wojciech Wieczorek; Agnieszka Szarpak; Mahdi Al-Jeabory; Wladyslaw Gawel; Aleksandra Gasecka; Milosz J Jaguszewski; Przemyslawa Jarosz-Chobot
Journal:  Acta Diabetol       Date:  2021-03-20       Impact factor: 4.280

8.  The effect of swimming exercise and powdered-Salicornia herbacea L. ingestion on glucose metabolism in STZ-induced diabetic rats.

Authors:  Se Sil Lee; Hyobin Seo; Sungpil Ryu; Tae-Dong Kwon
Journal:  J Exerc Nutrition Biochem       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.